ADXN CIK: 1574232

Addex Therapeutics Ltd.

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions CHF
FY21:
21.9
FY22:
7.83
FY23:
4.23
FY24:
3.54
FY25:
1.68
(positive)
Change from FY21 to FY25
millions CHF
FY21:
0.60
FY22:
0.45
FY23:
0.41
FY24:
7.14
FY25:
4.68
Total assets
Change from FY21 to FY25
millions CHF
FY21:
22.5
FY22:
8.28
FY23:
4.64
FY24:
10.7
FY25:
6.36

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions CHF
FY21:
4.13
FY22:
3.28
FY23:
2.89
FY24:
0.80
FY25:
1.20
(negative)
Change from FY21 to FY25
millions CHF
FY21:
1.48
FY22:
0.09
FY23:
0.60
FY24:
0.20
FY25:
0.40
(positive)
Change from FY21 to FY25
millions CHF
FY21:
16.9
FY22:
4.91
FY23:
1.15
FY24:
9.68
FY25:
4.77
Total liabilities & equity
Change from FY21 to FY25
millions CHF
FY21:
22.5
FY22:
8.28
FY23:
4.64
FY24:
10.7
FY25:
6.36

All amounts in millions CHF Data sources:SEC EDGARTwelve Data